FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2898001878> ?p ?o ?g. }

• W2898001878 endingPage "e0206140" @default.
• W2898001878 startingPage "e0206140" @default.
• W2898001878 abstract "Introduction Brain-Derived Neurotrophic Factor (BDNF) and its most common polymorphism Val66Met are known to have a role in Multiple Sclerosis (MS) pathogenesis. Evidence is accumulating that there is an involvement of DNA methylation in the regulation of BDNF expression. The aim of this study was to assess in blood samples of MS patients the correlation between the methylation status of the CpG site near BDNF-Val66Met polymorphism and the severity of the disease. Methods We recruited 209 MS patients that were genotyped for the BDNF Val66Met polymorphism. For each patient we quantitatively measured the methylation level of cytosine included in the exonic CpG site that can be created or abolished by the Val66Met BDNF polymorphism. Furthermore, we analyzed the clinical history of each patient and determined the time elapsed since the onset of the disease and an EDSS score of 6.0. Results The genetic analysis identified 122 (58.4%) subjects carrying the Val/Val genotype, 81 (38.8%) with Val/Met genotype, and 6 (2.8%) carrying the Met/Met genotype. When the endpoint of an EDSS score of 6 was taken into account by means of a survival analysis, 52 failures (i.e., reaching an EDSS score of 6) were reported. When the sample was stratified according to the percentage of the BDNF methylation, subjects falling below the median (median methylation = 81%) were at higher risk of failure (IRD = 0.016; 95%CI = 0.0050–0.0279; p = 0.004). Conclusions In patients with a high disease progression the hypomethylation of the BDNF gene could increase the secretion of the protective neurotrophin, so epigenetic modifications could be the organism response to limit a brain functional reserve loss. Our study suggests that the percentage of methylation of the BDNF gene could be used as a prognostic factor for disease progression toward a high disability in MS patient." @default.
• W2898001878 created "2018-10-26" @default.
• W2898001878 creator A5005439850 @default.
• W2898001878 creator A5008752460 @default.
• W2898001878 creator A5015782621 @default.
• W2898001878 creator A5021231532 @default.
• W2898001878 creator A5024633714 @default.
• W2898001878 creator A5026189897 @default.
• W2898001878 creator A5037098935 @default.
• W2898001878 creator A5069534962 @default.
• W2898001878 creator A5069807051 @default.
• W2898001878 creator A5078781677 @default.
• W2898001878 creator A5085497734 @default.
• W2898001878 creator A5088979800 @default.
• W2898001878 date "2018-10-23" @default.
• W2898001878 modified "2023-10-13" @default.
• W2898001878 title "BDNF rs6265 polymorphism methylation in Multiple Sclerosis: A possible marker of disease progression" @default.
• W2898001878 cites W1974119296 @default.
• W2898001878 cites W1989654415 @default.
• W2898001878 cites W2000209446 @default.
• W2898001878 cites W2007156391 @default.
• W2898001878 cites W2012423618 @default.
• W2898001878 cites W2015502121 @default.
• W2898001878 cites W2018949528 @default.
• W2898001878 cites W2023323938 @default.
• W2898001878 cites W2036524172 @default.
• W2898001878 cites W2044541726 @default.
• W2898001878 cites W2048660379 @default.
• W2898001878 cites W2074549018 @default.
• W2898001878 cites W2075235867 @default.
• W2898001878 cites W2077357002 @default.
• W2898001878 cites W2078727419 @default.
• W2898001878 cites W2094544368 @default.
• W2898001878 cites W2106680700 @default.
• W2898001878 cites W2112165124 @default.
• W2898001878 cites W2118094114 @default.
• W2898001878 cites W2121471393 @default.
• W2898001878 cites W2121963535 @default.
• W2898001878 cites W2130417276 @default.
• W2898001878 cites W2135959376 @default.
• W2898001878 cites W2139565721 @default.
• W2898001878 cites W2148491085 @default.
• W2898001878 cites W2152938275 @default.
• W2898001878 cites W2169748565 @default.
• W2898001878 cites W2232982392 @default.
• W2898001878 cites W2299660972 @default.
• W2898001878 cites W2314924074 @default.
• W2898001878 cites W2885695004 @default.
• W2898001878 cites W51414459 @default.
• W2898001878 cites W2119387814 @default.
• W2898001878 doi "https://doi.org/10.1371/journal.pone.0206140" @default.
• W2898001878 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6383920" @default.
• W2898001878 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30789956" @default.
• W2898001878 hasPublicationYear "2018" @default.
• W2898001878 type Work @default.
• W2898001878 sameAs 2898001878 @default.
• W2898001878 citedByCount "21" @default.
• W2898001878 countsByYear W28980018782019 @default.
• W2898001878 countsByYear W28980018782020 @default.
• W2898001878 countsByYear W28980018782021 @default.
• W2898001878 countsByYear W28980018782022 @default.
• W2898001878 countsByYear W28980018782023 @default.
• W2898001878 crossrefType "journal-article" @default.
• W2898001878 hasAuthorship W2898001878A5005439850 @default.
• W2898001878 hasAuthorship W2898001878A5008752460 @default.
• W2898001878 hasAuthorship W2898001878A5015782621 @default.
• W2898001878 hasAuthorship W2898001878A5021231532 @default.
• W2898001878 hasAuthorship W2898001878A5024633714 @default.
• W2898001878 hasAuthorship W2898001878A5026189897 @default.
• W2898001878 hasAuthorship W2898001878A5037098935 @default.
• W2898001878 hasAuthorship W2898001878A5069534962 @default.
• W2898001878 hasAuthorship W2898001878A5069807051 @default.
• W2898001878 hasAuthorship W2898001878A5078781677 @default.
• W2898001878 hasAuthorship W2898001878A5085497734 @default.
• W2898001878 hasAuthorship W2898001878A5088979800 @default.
• W2898001878 hasBestOaLocation W28980018781 @default.
• W2898001878 hasConcept C104317684 @default.
• W2898001878 hasConcept C126322002 @default.
• W2898001878 hasConcept C135763542 @default.
• W2898001878 hasConcept C140173407 @default.
• W2898001878 hasConcept C143998085 @default.
• W2898001878 hasConcept C150194340 @default.
• W2898001878 hasConcept C160539049 @default.
• W2898001878 hasConcept C170493617 @default.
• W2898001878 hasConcept C180754005 @default.
• W2898001878 hasConcept C190727270 @default.
• W2898001878 hasConcept C2778163459 @default.
• W2898001878 hasConcept C2778790584 @default.
• W2898001878 hasConcept C33288867 @default.
• W2898001878 hasConcept C54355233 @default.
• W2898001878 hasConcept C71924100 @default.
• W2898001878 hasConcept C86803240 @default.
• W2898001878 hasConcept C90924648 @default.
• W2898001878 hasConceptScore W2898001878C104317684 @default.
• W2898001878 hasConceptScore W2898001878C126322002 @default.
• W2898001878 hasConceptScore W2898001878C135763542 @default.
• W2898001878 hasConceptScore W2898001878C140173407 @default.
• W2898001878 hasConceptScore W2898001878C143998085 @default.

• next